Bookbuilding IPO | ₹70 Cr | Listed at BSE SME | Tue, Nov 11, 2025 - Thu, Nov 13, 2025
Mahamaya Lifesciences IPO IPO subscription status. Full data available on IPOMatrix.com.
| Category | QIB | NII | Retail | Total | ||||
|---|---|---|---|---|---|---|---|---|
| Ex. Anchor | Anchor Investor | Total QIB | Above ₹10L | Below ₹10L | Total NII | |||
| Allocation (No. of shares) | 58,69,200 | |||||||
| Allotment price (₹) | 114 | |||||||
| No. of applications | 1,024 | |||||||
| No. of shares applied | 87,03,600 | |||||||
|
🔒 Preview Limited Full data is available exclusively on IPOMatrix.com — your premium IPO research platform. 🗝️ Login to View All Records → |
||||||||
| Amount collected (₹ Cr.) | 99.22 Cr | |||||||
| No. of times subscribed | 1.48 | |||||||
| No. of shares allotted | 58,69,200 | |||||||
| Amount allotted (₹ Cr.) | 66.91 Cr | |||||||
| No. of allottees | 1,018 | |||||||
Mahamaya Lifesciences IPO is a public issue of 0.59 Cr equity shares. The issue offers 0.21 Cr shares to retail investors, 0.29 Cr shares to qualified institutional buyers, and 0.09 Cr shares to non-institutional investors.
| Category | Shares Offered | Amt (₹ Cr.) | Size (%) |
|---|---|---|---|
| Market Maker | 3,09,600 | 3.53 | 5.01% |
| QIB | 29,28,000 | 33.38 | 47.39% |
| Anchor | 17,52,000 | 19.97 | 28.36% |
| QIB (Ex Anchor) | 11,76,000 | 13.41 | 19.03% |
| NII* | 8,82,000 | 10.05 | 14.27% |
| bNII (> ₹10L) | 5,88,000 | 6.70 | 9.52% |
| sNII (< ₹10L) | 2,94,000 | 3.35 | 4.76% |
| Retail | 20,59,200 | 23.47 | 33.33% |
| Total | 61,78,800 | 70.44 | 100% |
A total of 17,52,000 shares at a price of Rs 114 per share will be allotted to the anchor investors.
| Bid Date | Nov 10, 2025 |
| Price | ₹114.00 |
| % of QIBs | 59.84% |
| Shares Locked (30 Days) | 8,76,000 |
| Shares Locked (90 Days) | 8,76,000 |
| # | Anchor | Group Entity | Shares Allotted | Amt (₹ cr.) | % Allocated | % Allotment of Issue |
|---|---|---|---|---|---|---|
| 1 | ABUNDANTIA CAPITAL VCC-ABUNDANTIA CAPITAL III | ABUNDANTIA | 2,64,000 | 3.01 | 15.07 | 4.27 |
| 2 | Ascend Global Opportunities Fund | ASCEND GLOBAL | 1,75,200 | 2.00 | 10.00 | 2.84 |
📊 Historic report - IPOs Anchor Investors Investment & Performance
The Mahamaya Lifesciences IPO is subscribed 1.48x.
Category-wise data available on IPOMatrix.com
Login to view QIB, NII, Retail and all category details
| Category | Subscription (times) |
|---|---|
| Total | 1.48x |
Mahamaya Lifesciences IPO total subscription is 1.48x.
Category-wise data available on IPOMatrix.com
Login to view QIB, NII, Retail and all category details
An investor can apply in Mahamaya Lifesciences IPO online via bank (using ASBA) or the broker (using UPI). The Mahamaya Lifesciences IPO shares are offered online only.
The Mahamaya Lifesciences IPO is subscribed 1.48x times.
The Mahamaya Lifesciences IPO allotment status is expected on or around Friday, November 14, 2025. Visit Mahamaya Lifesciences IPO allotment status to check.
The Mahamaya Lifesciences IPO listing date is November 18, 2025. The equity share of Mahamaya Lifesciences IPO will list on BSE SME.
Visit Mahamaya Lifesciences IPO subscription status page for real-time bidding information about Mahamaya Lifesciences IPO.
| IPO opens On | Tuesday, November 11, 2025 |
| IPO Closes On | Thursday, November 13, 2025 |
| Finalisation of Basis of Allotment | Friday, November 14, 2025 |
| Initiation of Refunds | Monday, November 17, 2025 |
| Credit of Shares to Demat Account | Monday, November 17, 2025 |
| IPO Listing Date | Tuesday, November 18, 2025 |
| IPO Details |
| IPO Recommendations |
| IPO Live Subscription |
| IPO FAQs |
